News
DVA
165.51
+0.83%
1.37
DaVita Reaches Analyst Target Price
NASDAQ · 2d ago
IXJ: Healthcare Sector Dashboard For November
Seeking Alpha · 5d ago
Weekly Report: what happened at DVA last week (1111-1115)?
Weekly Report · 6d ago
Alkermes, DaVita, Jabil, Ralph Lauren, among potential M&A candidates - BofA
Seeking Alpha · 11/17 14:18
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Benzinga · 11/17 07:49
Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q3 2024 Update
Seeking Alpha · 11/15 02:18
Berkshire Hathaway 13F Shows Increased Stake In American Express By 17% To 151.6M Shares, Now Worth $41.1B; Increased Stake In Kroger By 15% To 50M Shares, Worth $2.87B; Increased Stake In DaVita By 18%, Now Valued At $5.92B; Increased Stake In Moody's Corp By 13% To 24.67M Shares, Now Worth $11.71B
Benzinga · 11/14 21:59
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation
Seeking Alpha · 11/14 19:19
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
Benzinga · 11/14 16:42
Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?
Simply Wall St · 11/13 17:20
This microcap healthcare stock could double in value by 2027, analyst says
Seeking Alpha · 11/13 16:16
DaVita To Present At UBS Global Healthcare Conference 2024; Webcast At 3:30 PM ET
NASDAQ · 11/12 19:33
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health
PR Newswire · 11/12 14:05
Weekly Report: what happened at DVA last week (1104-1108)?
Weekly Report · 11/11 09:20
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
PR Newswire · 11/08 21:33
Truist Financial Remains a Hold on DaVita (DVA)
TipRanks · 11/06 12:33
Weekly Report: what happened at DVA last week (1028-1101)?
Weekly Report · 11/04 09:21
Barclays Remains a Hold on DaVita (DVA)
TipRanks · 11/04 09:17
DaVita Is Maintained at Equal-Weight by Barclays
Dow Jones · 10/31 18:21
More
Webull provides a variety of real-time DVA stock news. You can receive the latest news about Davita Inc through multiple platforms. This information may help you make smarter investment decisions.
About DVA
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.